Skip to main content
. Author manuscript; available in PMC: 2021 Dec 27.
Published in final edited form as: Acad Emerg Med. 2020 Jul 20;27(11):1140–1149. doi: 10.1111/acem.14070

Table 3.

Adverse events in sepsis intubations, stratified by induction agent. Only sepsis cases (n=531) are reported in this table.

Outcome Induction agent
Etomidate (n=363) Ketamine
(n=140)
Midazolam
(n=2)
Propofol
(n=8)
No meds
(n=17)
First-Pass Intubation Success, n (%) 322 (88.7) 118 (84.3) 1 (50.0) 8 (100.0) 14 (82.4)
Peri-Intubation Adverse Events, n (%) 81 (15.8) 38 (27.1) 1 (50.0) 1 (12.5) 1 (5.9)
Oxygen Desaturation (SpO2<90%), n (%) 41 (11.3) 16 (11.4) 2 (100.0) 1 (12.5) 1 (5.9)
Hypotension (SBP < 100 mmHg) within 15 minutes after medications, n (%) 182 (49.5) 100 (74.1) 1 (50.0) 1 (12.5) 3 (17.6)
Lowest SBP (mmHg), median (IQR) 72 (60–84) 74.5 (65–84) 95 (95–95) 70 (70–70) 60 (53–70)
Medications given within 15 minutes after induction
 Any treatment for hypotension, n (%) 136 (37.5) 76 (54.3) 2 (100.0) 1 (12.5) 3 (17.6)
 Vasopressor, n (%) 85 (23.4) 42 (30.0) 2 (100.0) 0 (0.0) 5 (29.4)
 Any sedation (including propofol, ketamine, morphine, midazolam, diazepam, fentanyl, etomidate, or morphine) n (%) 274 (75.5) 105 (75.0) 2 (100.0) 6 (75.0) 9 (52.9)
 Peri-Intubation adverse events OR post-intubation hypotension (<100mmHg), n (%) 82 (22.6) 41 (29.3) 2 (100.0) 1 (12.5) 1 (5.9)